US 12398212
Methods for treating or preventing asthma by administering an IL-4R antagonist
granted A61KA61K2039/505A61K2039/525
Quick answer
US patent 12398212 (Methods for treating or preventing asthma by administering an IL-4R antagonist) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Aug 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K2039/505, A61K2039/525, A61K2039/545, A61K39/12